Guinea pig (Cavia porcellus) are commonly recognized as one of the earliest used laboratory research animals. They share many similarities in biology and disease state progression with humans, making them ideal candidates for studying human illnesses. Research using Guinea Pigs has led to many important discoveries from Vitamin C to the bacteria Mycobacterium tuberculosis as the causative agent of tuberculosis. Study of diseases such as tuberculosis in Guinea Pig models has often relied on host mortality, bacterial loads, and qualitative assessment of pathology at necropsy. These are blunt tools, largely unrelated to the markers used for diagnosis and epidemiological studies of human tuberculosis. The lack of immunological reagents for Guinea Pigs has thus far hampered efforts to study disease states through relevant biomarkers. GlycoScientific has developed a range of antibodies against Guinea Pig cytokines and immunological markers such as STAT and JAK to fulfill this unmet need.
